<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03131388</url>
  </required_header>
  <id_info>
    <org_study_id>AMH 2.7.1</org_study_id>
    <nct_id>NCT03131388</nct_id>
  </id_info>
  <brief_title>Clinical Performance Evaluation of AMH Assay</brief_title>
  <official_title>Clinical Performance Evaluation of AMH Assay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beckman Coulter, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beckman Coulter, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility
      assessment. The purpose of the study is to evaluate the clinical performance of the Access
      AMH Assay in the intended use population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      same as brief summary
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of AMH as an aid for fertility assessment</measure>
    <time_frame>Day 2 to 4 of menstrual cycle</time_frame>
    <description>Comparison of AMH levels in women at different levels of AFC to aid in assessing ovarian reserve</description>
  </primary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Anti-Mullerian Hormone</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Access AMH Assay</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult women presenting to fertility clinics for fertility assessment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â‰¥ 21 and &lt; 46 years of age

          -  Regular menstrual cycle

          -  Both ovaries present

        Exclusion Criteria:

          -  Evidence of PCOS

          -  Confirmed ovarian endometrioma

          -  Ovarian surgery prior to enrollment

          -  Being treated for cancer

          -  Hormonal contraceptive use prior to enrollment

          -  Currently pregnant
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Lori Lofaro, MSHS</last_name>
    <email>lrlofaro@beckman.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>BRI</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Millie Behera, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Baker, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>FSMG</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arlene Morales, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>RAD</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Feinberg, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>WRMG</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Zbella, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vios Fertility</name>
      <address>
        <city>Swansea</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Cooper, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BIVF</name>
      <address>
        <city>Waltham</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Alper, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mainline Fertility</name>
      <address>
        <city>Bryn Mawr</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Glassner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Univ Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clarisa Gracia, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CARE</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Doody, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CORM</name>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicki Schnell, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>PNWF</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorna Marshall, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Ovo</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecile Le Saint, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2017</study_first_submitted>
  <study_first_submitted_qc>April 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2017</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

